In conclusion, the majority of myeloid neoplasm-associated gene variants in AA patients affected TET2, ASXL1 and MPL, and epigenetic- and signal transduction pathway-related genes were the most commonly involved. This evidence concerns the gene MPL and myeloid neoplasm.